2025-03-10 20:41:54
Latest Post
Syngene acquires its First Manufacturing Facility in the US 
Thermax Partners with Brazil-Based OCQ for High-Performance Chemicals
BEL receives orders worth Rs.843 Crore
RVNL signed MoU with M/s Abhinava Strategic Partners Pvt Ltd
Gensol Engineering promoter demonstrates unwavering commitment with INR 29 Cr. Equity Infusion
Stock Report
Rainbow Childrens Medicare Ltd Q4 FY23 consolidated PAT slips QoQ to Rs. 53.59 crores
Posted On : 2023-05-14 19:48:35( TIMEZONE : IST )
Rainbow Childrens Medicare Limited has reported Consolidated financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 325.864 crores during the period ended March 31, 2023 as compared to Rs. 314.775 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 53.595 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 57.917 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 5.31 for the period ended March 31, 2023 as compared to Rs. 5.74 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹325.864 crs | ₹314.775 crs |  3.52% |
| Net Profit | ₹53.595 crs | ₹57.917 crs |  -7.46% |
| EPS | ₹5.31 | ₹5.74 | -7.49% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.325.864 crores during the period ended March 31, 2023 as compared to Rs.218.633 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.53.595 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.12.194 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.5.31 for the period ended March 31, 2023 as compared to Rs.1.33 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹325.864 crs | ₹218.633 crs | 49.05% |
| Net Profit | ₹53.595 crs | ₹12.194 crs | 339.52% |
| EPS | ₹5.31 | ₹1.33 | 299.25% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.1204.439 crores during the Financial Year ended March 31, 2023 as compared to Rs.992.695 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.210.834 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.138.266 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.20.89 for the Financial Year ended March 31, 2023 as compared to Rs.14.45 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹1204.439 crs | ₹992.695 crs | 21.33% |
| Net Profit | ₹210.834 crs | ₹138.266 crs | 52.48% |
| EPS | ₹20.89 | ₹14.45 | 44.57% |
Shares of Rainbow Childrens Medicare Limited was last trading in BSE at Rs. 820.65 as compared to the previous close of Rs. 807.15. The total number of shares traded during the day was 3235 in over 599 trades.
The stock hit an intraday high of Rs. 825.20 and intraday low of 806.95. The net turnover during the day was Rs. 2647425.00.
